Production of a Plant-Derived Immunogenic Protein Targeting ApoB100 and CETP: Toward a Plant-Based Atherosclerosis Vaccine

Molecular Biotechnology

Volumn 56, Issue 12, 2014, Pages 1133-1142

  Salazar Gonzalez, Jorge Alberto ^a   Rosales Mendoza, Sergio ^a   Romero Maldonado, Andrea ^a   Monreal Escalante, Elizabeth ^a   Uresti Rivera, Edith Elena ^a   Bañuelos Hernández, Bernardo ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

ApoB100; Atherosclerosis; CETP; Immunotherapy; Plant derived vaccine

Indexed keywords

DISEASES; EPITOPES; MAMMALS; POLYMERASE CHAIN REACTION; VACCINES;

APOB100; ATHEROSCLEROSIS; CETP; CHOLERA TOXIN B SUBUNIT; HUMAN SERUM PROTEINS; IMMUNOTHERAPY; PROTEIN ACCUMULATION; WESTERN-BLOT ANALYSIS;

RECOMBINANT PROTEINS;

APOLIPOPROTEIN B100; ATHEROSCLEROSIS VACCINE; BCR ABL PROTEIN; CHIMERIC PROTEIN; CHOLERA TOXIN B SUBUNIT; CHOLESTEROL ESTER TRANSFER PROTEIN; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; RECOMBINANT PROTEIN; SYNTHETIC DNA; UNCLASSIFIED DRUG; VACCINE; CHOLERA TOXIN; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; BIOMASS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; COPY NUMBER VARIATION; DRUG FORMULATION; DRUG MANUFACTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOTHERAPY; LEAF TISSUE; MOLECULAR CLONING; MOLECULAR FARMING; MOUSE; NICOTIANA TABACUM; NONHUMAN; PHENOTYPE; PLANT LEAF; POLYMERASE CHAIN REACTION; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TH2 CELL; TRANSGENE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; GENETICS; IMMUNOLOGY; TOBACCO; TRANSGENIC PLANT;

MUS; NICOTIANA OBTUSIFOLIA;

ANIMALS; APOLIPOPROTEIN B-100; ATHEROSCLEROSIS; CHOLERA TOXIN; CHOLESTEROL ESTER TRANSFER PROTEINS; EPITOPES; MICE; PLANTS, GENETICALLY MODIFIED; RECOMBINANT FUSION PROTEINS; TOBACCO; VACCINES;

EID: 84919905786     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-014-9793-6     Document Type: Article

References (39)

1. Tabas, I., Williams, K. J., & Boren, J. (2007). Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications. Circulation,116, 1832–1844.
2. Hartvigsen, K., Chou, M. Y., Hansen, L. F., Shaw, P. X., Tsimikas, S., Binder, C. J., et al. (2009). The role of innate immunity in atherogenesis. Journal of Lipid Research,50(Suppl.), S388–S393.
3. Feig, J. E., Shamir, R., & Fisher, E. A. (2008). Atheroprotective effects of HDL: Beyond reverse cholesterol transport. Current Drug Targets,9, 196–203.
4. Perreault, S., Blais, L., Lamarre, D., Dragomir, A., Berbiche, D., Lalonde, L., et al. (2005). Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. British Journal of Clinical Pharmacology,59, 564–573.
5. Bates, T. R., Connaughton, V. M., & Watts, G. F. (2009). Non-adherence to statin therapy: A major challenge for preventive cardiology. Expert Opinion on Pharmacotherapy,10, 2973–2985.
6. Fredrikson, G. N., Andersson, L., Söderberg, I., Dimayuga, P., Chyu, K. Y., Shah, P. K., et al. (2005). Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Autoimmunity,38, 171–179.
7. Schiopu, A., Bengtsson, J., Söderberg, I., Janciauskiene, S., Lindgren, S., Ares, M. P., et al. (2004). Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation,110, 2047–2052.
8. Klingenberg, R., Lebens, M., Hermansson, A., Fredrikson, G. N., Strodthoff, D., Rudling, M., et al. (2010). Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology,30, 946–952.
9. Chyu, K. Y., Zhao, X., Dimayuga, P. C., Zhou, J., Li, X., Yano, J., et al. (2012). CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide. PLoS ONE,7, 1–12.
10. Rittershaus, C. W., Miller, D. P., Thomas, L. J., Picard, M. D., Honan, C. M., Emmett, C. D., et al. (2000). Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology,20, 2106–2112.
11. Davidson, M. H., Maki, K., Umporowicz, D., Wheeler, A., Rittershaus, C., & Ryan, U. (2003). The safety and immunogenicity of a CETP vaccine in healthy adults. Atherosclerosis,169, 113–120.
12. Thomas, L., Hammond, R., Forsberg, E., Geoghegan-Barek, K., Karalius, B., Marsh, H., et al. (2009). Co-administration of a CpG adjuvant (VaxImmuneTM, CPG 7909) with CETP vaccines increased immunogenicity in rabbits and mice. Human Vaccines,5, 79–84.
13. Gaofu, Q., Jun, L., Xiuyun, Z., Wentao, L., Jie, W., & Jingjing, L. (2005). Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit model. Life Sciences,77, 2690–2702.
14. Barter, P. J., Hopkins, G. J., & Calvert, G. D. (1982). Transfers and exchanges of esterified cholesterol between plasma lipoproteins. Biochemical Journal,208, 1–7.
15. von Eckardstein, A., Nofer, J. R., & Assmann, G. (2001). HDL and coronary heart disease: Role of cholesterol efflux and reverse cholesterol transport. Arteriosclerosis, Thrombosis, and Vascular Biology,20, 13–27.
16. Curtis, R. I., & Cardineau, C. A. (1990). Oral immunization by transgenic plants. World Patent Application. WO 90/02484.
17. Yusibov, V., Streatfield, S. J., & Kushnir, N. (2011). Clinical development of plant-produced recombinant pharmaceuticals. Vaccines, antibodies and beyond. Human Vaccines,7, 313–321.
18. Mason, H. S., & Herbst-Kralovetz, M. M. (2012). Plant-derived antigens as mucosal vaccines. Current Topics in Microbiology and Immunology,354, 101–120.
19. Santi, L., Batchelor, L., Huang, Z., Hjelm, B., Kilbourne, J., Arntzen, C. J., et al. (2008). An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine,26, 1846–1854.
20. Lawson, L. B., Norton, E. B., & Clements, J. D. (2011). Defending the mucosa: Adjuvant and carrier formulations for mucosal immunity. Current Opinion in Immunology,23, 414–420.
21. Salazar-González, J. A., & Rosales-Mendoza, S. (2013). A perspective for atherosclerosis vaccination: Is there a place for plant-based vaccines? Vaccine,31, 1364–1369.
22. Cangelosi, G. A., Best, E. A., Martinetti, G., & Nester, E. W. (1991). Genetic analysis of Agrobacterium. Methods in Enzymology,204, 384–397.
23. Horsch, R. B., Fry, J. E., Hoffmann, N. L., Eichholtz, D., Rogers, S. G., & Fraley, R. T. (1985). A simple and general method for transferring genes into plants. Science,227, 1229–1231.
24. Dellaporta, S. L., Wood, J., & Hicks, J. B. (1983). A plant DNA minipreparation: Version II. Plant Molecular Biology Reporter,1, 19–21.
25. Weng, H., Pan, A., Yang, L., Zhang, C., Liu, Z., & Zhang, D. (2004). Estimating number of transgene copies in transgenic rapeseed by real-time PCR assay with HMG I/Y as an endogenous reference gene. Plant Molecular Biology Reporter,22, 289–300.
26. Chikwamba, R., Cunnick, J., Hathaway, D., McMurray, J., Mason, H., & Wang, K. (2002). A functional antigen in a practical crop: Maize synthesized LT-B protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT). Transgenic Research,11, 479–493.
27. Gaofu, Q., Jingjing, L., Shengying, W., Shanshan, X., Peng, D., Qingye, Z., et al. (2011). A chimeric peptide of intestinal trefoil factor containing cholesteryl ester transfer protein B cell epitope significantly inhibits atherosclerosis in rabbits after oral administration. Peptides,32, 790–796.
28. Ruhlman, T., Ahangari, R., Devine, A., Samsam, M., & Daniell, H. (2007). Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts—oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnology Journal,5, 495–510.
29. Youm, J. W., Jeon, J. H., Kim, H., Kim, Y. H., Ko, K., Joung, H., et al. (2008). Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease. Biotechnology Letters,30, 1839–1845.
30. McCormick, A. A., Reddy, S., Reinl, S. J., Cameron, T. I., Czerwinkski, D. K., Vojdani, F., et al. (2008). Plant-produced idiotype vaccines for the treatment of non-Hodgkin’s lymphoma: Safety and immunogenicity in a phase I clinical study. Proceedings of the National Academy of Sciences of the United States of America,105, 10131–10136.
31. Kim, T. G., Gruber, A., & Langridge, W. H. (2004). HIV-1 gp120 V3 cholera toxin B subunit fusion gene expression in transgenic potato. Protein Expression and Purification,37, 196–202.
32. Lee, J. Y., Yu, J., Henderson, D., & Langridge, W. H. (2004). Plant-synthesized E. coli CFA/I fimbrial protein protects Caco-2 cells from bacterial attachment. Vaccine,23, 222–231.
33. Sharma, M. K., Singh, N. K., Jani, D., Sisodia, R., Thungapathra, M., Gautam, J. K., et al. (2008). Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). Plant Cell Reports,27, 307–318.
34. Li, D., O’Leary, J., Huang, Y., Huner, N. P., Jevnikar, A. M., & Ma, S. (2006). Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants. Plant Cell Reports,25, 417–424.
35. Greco, R., Michel, M., Guetard, D., Cervantes-Gonzalez, M., Pelucchi, N., Wain-Hobson, S., et al. (2007). Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine,25, 8228–8240.
36. Rigano, M. M., Dreitz, S., Kipnis, A. P., Izzo, A. A., & Walmsley, A. M. (2006). Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine. Vaccine,24, 691–695.
37. Kim, S. I., Veena, J. H., & Gelvin, S. B. (2007). Genome-wide analysis of Agrobacterium T-DNA integration sites in the Arabidopsis genome generated under non-selective conditions. Plant Journal,51, 779–791.
38. Tse, K., Gonen, A., Sidney, J., Ouyang, H., Witztum, J. L., Sette, A., et al. (2013). Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100. Frontiers in Immunology,4, 493.
39. Baldwin, I. T. (1988). Damaged-induced alkaloids in tobacco: Pot-bound plants are not inducible. Journal of Chemical Ecology,4, 1113–1120.